Intensifying competition in the domestic CRO market is eroding profits, BiDe Pharmaceutical claims it will strengthen its overseas market | Direct hit earnings conference
①Affected by factors such as the slowdown in funding for innovative drugs and the increased competition among CRO companies, the domestic revenue of BiDe Medical continues to decline, dragging down overall performance and leading to a sharp decline in net income; ②In contrast, overseas market revenue is still growing. Chairman of BiDe Medical, Dai Lan, revealed that in the future, they will correspondingly increase overseas BD personnel to carry out promotional work.
Witness history! The sse composite index surged by 10%! All A-share brokerages hit the limit up! Semiconductors almost all hit the limit up.
After the National Day holiday, the A-share king is back!
Hunan oil pump: plans to invest in the construction of two large overseas bases, with an annual output of 3.5 million units of new energy electronic pump project in progress | Earnings conference
① Currently, Hunan Oil Pump's two major overseas production bases are preparing for construction according to plan; ② To observe the future production capacity increase, one should look at the progress of the annual production of 3.5 million new energy electronic pump intelligent manufacturing project.
Fuchuang Precision: Acquisition matters are being discussed with multiple parties | Directly targeting the earnings conference
①Zheng Guangwen, Chairman of Fuchuang Precision, stated today that the company's current orders are relatively sufficient, the operation is stable, and the existing production capacity can effectively meet the delivery requirements of customers; ②Regarding the acquisition of 100% equity of Yisheng Precision, Zheng Guangwen stated that the acquisition is currently being discussed with multiple parties, and completion of the acquisition will help enhance the company's comprehensive service capabilities.
Top oncology conference is coming! Multiple popular anti-cancer drugs will debut, involving these A-share companies.
①The annual meeting of the European Society for Medical Oncology will be held in Barcelona, Spain in 2024; ②At the meeting, Beigene, Jiangsu Hengrui Pharmaceuticals and other listed companies will release the latest data on their oncology drugs; ③In addition, the conference will also discuss cutting-edge topics such as the impact of artificial intelligence on the diagnosis and treatment of tumors.
Seven companies were announced to be selected in the sixth batch of national specialized, special and new "little giant" list update|Speed Announcement
①Companies in industries such as pharmaceutical manufacturing and automotive spare parts have been selected as the sixth batch of national specialized, special, and new "little giant" list. ②Two of these companies had a net loss in the first half of the year.